Bristol Myers Squibb Co.

NYS: BMY

GO
/marketstate/country/us

Before the Bell

BMY
/zigman2/quotes/202559280/composite

$

59.64

Change

+0.15 +0.25%

Volume

Volume 79

Sep 28, 2020, 4:04 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/202559280/composite

Previous close

$ 59.49

$ 59.49

Change

+1.24 +2.13%

Day low

Day high

$58.16

$59.84

Open
Open: 58.26

52 week low

52 week high

$45.76

$68.34

Open

Market cap

$134.09B

Average volume

9.63M

P/E ratio

N/A

Rev. per Employee

$968,283

EPS

-0.10

Dividend

0.45

Div yield

3.03%

Ex dividend date

10/1/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bmy

MarketWatch News on BMY

  1. Philip Morris and American Tower Boost Their Dividends

    8:30 a.m. Sept. 12, 2020

    - Lawrence C. Strauss

  2. U.S. Drug Stocks Are Cheap Relative to the S&P 500

    10:20 a.m. Sept. 11, 2020

    - Andrew Bary

  3. 5 Biotech Stocks That Could Be Worth a Look

    10:44 p.m. Aug. 26, 2020

    - Bill Alpert

  4. 5 New Stocks That Are Hedge Funds’ Favorites

    3:44 p.m. Aug. 21, 2020

    - Carleton English

  5. Nasdaq Closes Above 11,000 for First Time

    4:21 p.m. Aug. 6, 2020

    - Callum Keown

  6. Bristol Myers Q2 raises 2020 adj. EPS outlook to $6.10-$6.25 from $6.00-$6.20

    7:03 a.m. Aug. 6, 2020

    - Tomi Kilgore

  7. Bristol Myers Q2 revenue $10.13 bln vs. $6.27 bln a year ago; FactSet consensus $9.99 bln

    7:02 a.m. Aug. 6, 2020

    - Tomi Kilgore

  8. Bristol Myers Q2 adj. EPS $1.63; FactSet consensus $1.48

    7:02 a.m. Aug. 6, 2020

    - Tomi Kilgore

  9. Bristol Myers Q2 per-share loss 4 cents vs. EPS 87 cents a year ago

    7:01 a.m. Aug. 6, 2020

    - Tomi Kilgore

  10. Bristol-Myers, Pfizer stocks rise on blood-thinner patent win

    6:28 p.m. Aug. 5, 2020

    - Wallace Witkowski

  11. Buy Merck for Its Unappreciated Pipeline, Says Goldman

    10:47 a.m. Aug. 3, 2020

    - Bill Alpert

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bmy

Other News on BMY

  1. Immunome Aims For $30 Million U.S. IPO

    11:49 a.m. Sept. 27, 2020

    - Seeking Alpha

  2. Dividend Champion And Contender Highlights: Week Of September 27

    11:03 a.m. Sept. 26, 2020

    - Seeking Alpha

  3. Dividend Champion And Contender Highlights: Week Of September 27

    11:03 a.m. Sept. 26, 2020

    - Seeking Alpha

  4. Bristol-Myers' Opdivo Meets Goals in Bladder Cancer Study

    5:09 p.m. Sept. 25, 2020

    - Zacks.com

  5. Raymond James Keeps a Buy Rating on Bristol Myers (BMY)

    4:45 p.m. Sept. 25, 2020

    - SmarterAnalyst

  6. FDA issues final rule for importation of drugs from abroad

    7:21 a.m. Sept. 25, 2020

    - Seeking Alpha

  7. Wide-Moat Stocks On Sale - The October 2020 Heat Map

    2:24 a.m. Sept. 25, 2020

    - Seeking Alpha

  8. Mixed Data From ESMO Sets Up The Next Fight For Exelixis

    12:54 p.m. Sept. 24, 2020

    - Seeking Alpha

  9. William Blair Maintains a Buy Rating on Bristol Myers (BMY)

    7:16 a.m. Sept. 23, 2020

    - SmarterAnalyst

  10. Bristol Myers (BMY) Gets a Buy Rating from Raymond James

    5:07 a.m. Sept. 23, 2020

    - SmarterAnalyst

  11. Loading more headlines...
/news/pressrelease/company/us/bmy

Press Releases on BMY

  1. Larynx Cancer Market Pipeline Insight and Competitive Landscape 2020

    3:32 a.m. Today

    - Market Insight Reports

  2. Biologics Market Size, Trends, Companies, Driver, Segmentation, Forecast to 2025

    2:37 a.m. Today

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.